Floatz logo

Trigonella Foenum-Graecum Seed Extract

Overweight and Obesity

University of Veterinary and Animal Sciences, Lahore - PakistanN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

26 Active assets in the Overweight and Obesity cohort.

Asset / SponsorPhaseRating
da-302168s
Chendu DIAO Pharmaceutical Group CO., LTD.
Phase 3BB
POTASSIUM CATION
Brigham and Women's Hospital
Phase 4BB
Polyglucosamine Glucomannan High Dose
Heilpflanzenwohl AG
Phase 4BB
CYANOCOBALAMINUM
The University of Texas Health Science Center, Houston
Phase 4BB
Chlorthalidone
Brigham and Women's Hospital
Phase 4BB

View all 47 →

Same molecule, other indications

Trigonella Foenum-Graecum Seed Extract is also rated in:

metabolic dysfunction-associated steatotic liver diseaseDormant
CCC
Indicative ·
55 / 100
View asset →
type 2 diabetes mellitusDormant
D
Indicative ·
30 / 100
View asset →
Obesity and Type 2 DiabetesDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →